Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

被引：0
|
作者：
Claire von Mollendorf
Mukhchuluun Ulziibayar
Bradford D. Gessner
Lien Anh Ha Do
Cattram D. Nguyen
Rohini Beavon
Bujinlkham Suuri
Dashtseren Luvsantseren
Dorj Narangerel
Adam Jenney
Eileen M. Dunne
Catherine Satzke
Badarchiin Darmaa
Tuya Mungun
E. Kim Mulholland
机构：
[1] Royal Children’s Hospital,Infection and Immunity, New Vaccines Research Group, Murdoch Children’s Research Institute
[2] The University of Melbourne,Department of Paediatrics
[3] Ministry of Health,National Center for Communicable Diseases (NCCD)
[4] Pfizer Vaccines,Department of Infectious Diseases, The Alfred Hospital
[5] Pfizer Vaccines,Department of Microbiology and Immunology
[6] Ministry of Health,Department of Infectious Disease Epidemiology
[7] Monash University,undefined
[8] The University of Melbourne at the Peter Doherty Institute for Infection and Immunity,undefined
[9] London School of Hygiene and Tropical Medicine,undefined
来源：
BMC Public Health | / 21卷
关键词：
Pneumococcal conjugate vaccine; Mongolia; Adult pneumonia; Surveillance; Indirect PCV impact; Nasopharyngeal carriage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
    Turner, Paul
    Turner, Claudia
    Suy, Kuong
    Soeng, Sona
    Ly, Sokeng
    Miliya, Thyl
    Goldblatt, David
    Day, Nicholas P. J.
    EMERGING INFECTIOUS DISEASES, 2015, 21 (11) : 2080 - 2083
  • [32] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
    Waight, Pauline A.
    Andrews, Nicholas J.
    Ladhani, Shamez N.
    Sheppard, Carmen L.
    Slack, Mary P. E.
    Miller, Elizabeth
    LANCET INFECTIOUS DISEASES, 2015, 15 (05): : 535 - 543
  • [33] Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France
    Levy, Corinne
    Varon, Emmanuelle
    Picard, Capucine
    Bechet, Stephane
    Martinot, Alain
    Bonacorsi, Stephane
    Cohen, Robert
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (12) : 1216 - 1221
  • [34] Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
    Alexandrova Nikolova, Kristiana
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2024, 12 (02)
  • [35] Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
    Patel, Sweta M.
    Shaik-Dasthagirisaheb, Yazdani B.
    Congdon, Morgan
    Young, Rebecca R.
    Patel, Mohamed Z.
    Mazhani, Tiny
    Boiditswe, Sefelani
    Leburu, Tirayaone
    Lechiile, Kwana
    Arscott-Mills, Tonya
    Steenhoff, Andrew P.
    Feemster, Kristen A.
    Shah, Samir S.
    Cunningham, Coleen K.
    Pelton, Stephen I.
    Kelly, Matthew S.
    PLOS ONE, 2022, 17 (01):
  • [36] Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era
    Shaughnessy, Erin E.
    Stalets, Erika L.
    Shah, Samir S.
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (06) : 786 - 793
  • [37] Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13-Valent polysaccharide conjugate vaccine
    Alicino, C.
    Barberis, I.
    Orsi, A.
    Durando, P.
    MINERVA MEDICA, 2014, 105 (01) : 89 - 97
  • [38] Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study
    Schuck-Paim, Cynthia
    Taylor, Roberti
    Alonso, Wladimirj
    Weinberger, Daniel M.
    Simonsen, Lone
    LANCET GLOBAL HEALTH, 2019, 7 (02): : E249 - E256
  • [39] Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)
    Sando, Eiichiro
    Suzuki, Motoi
    Furumoto, Akitsugu
    Asoh, Norichika
    Yaegashi, Makito
    Aoshima, Masahiro
    Ishida, Masayuki
    Hamaguchi, Sugihiro
    Otsuka, Yoshihito
    Morimoto, Konosuke
    VACCINE, 2019, 37 (20) : 2687 - 2693
  • [40] Correction to: Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain
    Susanna Hernández-Bou
    Borja Gómez
    Santiago Mintegi
    Juan J. García-García
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1457 - 1457
12345